The Power of Molecular Genotyping for Sickle Cell Patients

2 June 2014

The Immucor PreciseTypeTM HEA test is the first FDA-approved molecular assay, designed to provide clinicians and blood banks with the detailed genetic matching information they need to reduce the risk of alloimmunization and serious hemolytic reactions. Watch this video to hear Trey, a sickle cell patient, discussing how blood transfusions help him to cope with his disorder.